Sunny Guin

855 total citations
27 papers, 646 citations indexed

About

Sunny Guin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Sunny Guin has authored 27 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Sunny Guin's work include Liver physiology and pathology (6 papers), Cancer Genomics and Diagnostics (5 papers) and Prostate Cancer Treatment and Research (5 papers). Sunny Guin is often cited by papers focused on Liver physiology and pathology (6 papers), Cancer Genomics and Diagnostics (5 papers) and Prostate Cancer Treatment and Research (5 papers). Sunny Guin collaborates with scholars based in United States, China and Italy. Sunny Guin's co-authors include Dan Theodorescu, Ming‐Hai Wang, Yong-Qing Zhou, Qi Ma, Hangping Yao, Carolyn R. Lew, Charles R. Owens, Ruiwen Zhang, Yuanbin Ru and Ruiwen Zhang and has published in prestigious journals such as Nature, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Sunny Guin

26 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sunny Guin United States 16 349 180 117 112 98 27 646
Alessandro Furlan France 13 491 1.4× 149 0.8× 119 1.0× 127 1.1× 111 1.1× 28 792
Kesen Xu China 17 271 0.8× 243 1.4× 60 0.5× 177 1.6× 57 0.6× 32 675
Sujatha Jagadeeswaran United States 12 465 1.3× 360 2.0× 89 0.8× 197 1.8× 169 1.7× 16 973
Virna Cepero Italy 7 355 1.0× 217 1.2× 120 1.0× 80 0.7× 146 1.5× 7 638
Yi‐Hung Carol Tan United States 17 344 1.0× 255 1.4× 54 0.5× 90 0.8× 200 2.0× 32 705
Junbin Liao China 15 703 2.0× 216 1.2× 142 1.2× 404 3.6× 114 1.2× 19 1.0k
Qiong Xue China 13 451 1.3× 258 1.4× 207 1.8× 309 2.8× 59 0.6× 22 872
Mónica Musteanu Spain 14 415 1.2× 552 3.1× 64 0.5× 181 1.6× 149 1.5× 32 972
Silvia Fenoglio United States 5 534 1.5× 315 1.8× 97 0.8× 160 1.4× 163 1.7× 5 811

Countries citing papers authored by Sunny Guin

Since Specialization
Citations

This map shows the geographic impact of Sunny Guin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunny Guin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunny Guin more than expected).

Fields of papers citing papers by Sunny Guin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunny Guin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunny Guin. The network helps show where Sunny Guin may publish in the future.

Co-authorship network of co-authors of Sunny Guin

This figure shows the co-authorship network connecting the top 25 collaborators of Sunny Guin. A scholar is included among the top collaborators of Sunny Guin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunny Guin. Sunny Guin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jun, Tomi, Sunny Guin, Vaibhav G. Patel, et al.. (2022). MP27-10 CLINICAL UTILITY OF NEXT-GENERATION SEQUENCING FOR PROSTATE CANCER IN THE CONTEXT OF A CHANGING TREATMENT LANDSCAPE. The Journal of Urology. 207(Supplement 5).
2.
Guin, Sunny, Tomi Jun, Kristin L. Ayers, et al.. (2022). Management of de novo metastatic hormone-sensitive prostate cancer: A comprehensive report of a single-center experience. PLoS ONE. 17(8). e0264800–e0264800. 1 indexed citations
3.
Mack, Philip C., Kristin L. Ayers, Xiang Zhou, et al.. (2022). Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma. The Oncologist. 27(6). 476–486. 25 indexed citations
4.
Guin, Sunny, Tomi Jun, Vaibhav G. Patel, et al.. (2022). Extraction of Treatment Information From Electronic Health Records and Evaluation of Testosterone Recovery in Patients With Prostate Cancer. JCO Clinical Cancer Informatics. 6(6). e2200010–e2200010. 2 indexed citations
5.
Mack, Philip C., Kristin L. Ayers, Sunny Guin, et al.. (2021). Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers with Lung Adenocarcinoma. SSRN Electronic Journal. 1 indexed citations
6.
Guin, Sunny, et al.. (2017). Involvement of glycogen debranching enzyme in bladder cancer. Biomedical Reports. 6(6). 595–598. 4 indexed citations
7.
Ru, Yuanbin, et al.. (2016). CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL). BMC Cancer. 16(1). 713–713. 25 indexed citations
8.
Guin, Sunny, Yuanbin Ru, Neeraj Agarwal, et al.. (2015). Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis. Clinical Cancer Research. 22(5). 1274–1283. 24 indexed citations
9.
Guin, Sunny & Dan Theodorescu. (2015). The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer. Acta Pharmacologica Sinica. 36(3). 291–297. 33 indexed citations
10.
Lew, Carolyn R., Sunny Guin, & Dan Theodorescu. (2015). Targeting glycogen metabolism in bladder cancer. Nature Reviews Urology. 12(7). 383–391. 58 indexed citations
11.
Griner, Erin, Garrett M. Dancik, James C. Costello, et al.. (2014). RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer. Molecular Cancer Research. 13(3). 483–492. 15 indexed citations
12.
Guin, Sunny, Courtney Pollard, Yuanbin Ru, et al.. (2014). Role in Tumor Growth of a Glycogen Debranching Enzyme Lost in Glycogen Storage Disease. JNCI Journal of the National Cancer Institute. 106(5). 36 indexed citations
13.
Yan, Chao, Degang Liu, Liwei Li, et al.. (2014). Discovery and characterization of small molecules that target the GTPase Ral. Nature. 515(7527). 443–447. 112 indexed citations
14.
Guin, Sunny, Yuanbin Ru, Murry W. Wynes, et al.. (2013). Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression. Journal of Thoracic Oncology. 8(12). 1492–1501. 39 indexed citations
15.
Yao, Hangping, Yong-Qing Zhou, Qi Ma, et al.. (2011). The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells. Molecular Cancer. 10(1). 82–82. 41 indexed citations
16.
17.
18.
Wang, Ming‐Hai, et al.. (2010). Potential therapeutics specific to c-MET/RON receptor tyrosine kinases for molecular targeting in cancer therapy. Acta Pharmacologica Sinica. 31(9). 1181–1188. 40 indexed citations
19.
Guin, Sunny, et al.. (2010). Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase. Cancer Chemotherapy and Pharmacology. 67(5). 1073–1083. 17 indexed citations
20.
Ma, Qi, Kun Zhang, Sunny Guin, Yong-Qing Zhou, & Ming‐Hai Wang. (2010). Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase. Molecular Cancer. 9(1). 307–307. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandro Furlan Breakdown of academic impact, for papers by Kesen Xu Breakdown of academic impact, for papers by Sujatha Jagadeeswaran Breakdown of academic impact, for papers by Virna Cepero Breakdown of academic impact, for papers by Yi‐Hung Carol Tan Breakdown of academic impact, for papers by Junbin Liao Breakdown of academic impact, for papers by Qiong Xue Breakdown of academic impact, for papers by Mónica Musteanu Breakdown of academic impact, for papers by Silvia Fenoglio
Rankless by CCL
2026